13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Stroke and Cerebrovascular Diseases
Stroke and cerebrovascular diseases pose significant public health challenges, affecting millions worldwide and placing substantial burdens on healthcare systems. Stemming from disruptions in blood flow to the brain, these conditions lead to cascading events that can result in devastating neurological deficits and, in severe cases, death. Stroke, the most common cerebrovascular event, occurs when blood flow to a part of the brain is obstructed, either by a blood clot (ischemic stroke) or a ruptured blood vessel (hemorrhagic stroke). The consequences of stroke can be profound, ranging from paralysis and speech impairment to cognitive dysfunction and emotional disturbances. Beyond stroke, cerebrovascular diseases encompass conditions like transient ischemic attacks (TIAs), cerebral aneurysms, arteriovenous malformations (AVMs), and carotid artery stenosis. These conditions often share common risk factors such as hypertension, diabetes, smoking, obesity, and sedentary lifestyles. Early diagnosis and intervention are crucial in managing stroke and cerebrovascular diseases to mitigate brain damage and prevent long-term disability. Treatment strategies may include thrombolytic therapy, mechanical thrombectomy, and surgical interventions like carotid endarterectomy or stenting to restore blood flow in narrowed or blocked arteries.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States